Hong Kong Stock Movement: MiniMax's Listing Ignites AI Healthcare, XUNFEIHEALTH's Stock Price Soars 14.71%

Hong Kong Stock MovementXUNFEIHEALTH rose 14.71%. Based on recent news,On January 9, the domestic large model company MiniMax surged over 100% on its first day of listing, igniting artificial intelligence applications and driving up XUNFEIHEALTH's stock price. XUNFEIHEALTH's gains expanded to 25% at the end of trading, closing up 20.58% at HKD 97.55, with a transaction volume of HKD 190 million. Source: Zhitong FinanceOn January 8, OpenAI launched the ChatGPT Health feature, which can answer health questions, connect smart devices, and plan diet and exercise, similar to "Ant Fortune." Dongbei Securities believes that large model manufacturers are further strengthening their layout in the medical field, which has become one of the key areas of focus, coupled with policy support, AI healthcare is expected to further develop. Source: Zhitong FinanceOn January 11, the capital market is re-pricing AI companies, and XUNFEIHEALTH secured a national-level pilot base project, standing at a new competitive starting point. The popularity of health assistants is accelerating the industry, but the underlying system capabilities will still determine long-term outcomes. Source: Zhitong Finance AI healthcare field is intensively catalyzed, with continuous strengthening of policy support.Stocks with High Trading Volume in the IndustryInsilico Medicine rose 13.40%. Based on recent key news:On January 12, Insilico Medicine announced that its innovative candidate drug Garutadustat completed the first dosing of a subject in Phase IIa clinical trials. This drug, developed by the Pharma.AI platform, aims to treat inflammatory bowel disease and has a unique dual-action mechanism, driving up the stock price. Source: Economic Information DailyOn January 12, Insilico Medicine's drug Garutadustat received approval from the United States Adopted Names Council, further enhancing market confidence, leading to a rise in stock price. Source: Huigang CommunicationsOn January 12, Insilico Medicine attracted high-profile investors including Eli Lilly, Tencent, and Temasek Holdings after its listing in Hong Kong, boosting market confidence in its future development. Source: WSJ The biotechnology industry is active in innovative drug research and development.Medical Pulse rose 12.65%, with a transaction volume reaching HKD 319 million, and no significant news recently. Trading is active, with clear capital flow; considering the sector and industry trends, this stock shows significant volatility, and specific reasons need further observation.Brainstorm Aurora-B rose 1.90%. Based on recent key news:On January 12, Brainstorm Aurora-B recorded large trades in pre-market trading, with the transaction price 8.55% lower than the previous close, affecting stock price fluctuations. This transaction involved an amount of HKD 53.92 million, indicating increased market attention on this stock.On January 8, shareholders of Brainstorm Aurora-B deposited shares into HSBC Hong Kong and Shanghai Banking Corporation, with a warehouse market value of HKD 742 million, accounting for 8.13%. This move may reflect shareholders' confidence in the company's future development, driving up the stock priceThe interim performance of Brain 动极光-B as of June 30, 2025, shows a year-on-year revenue increase of 92.82%, but the net loss has also increased. Despite the widening losses, the revenue growth indicates the potential for business expansion, boosting market confidence. The Hong Kong stock market has recently experienced increased volatility, which needs attention.Stocks ranked among the top in market capitalization in the industryYidu Technology, up 11.17%, with a market capitalization of HKD 6.958 billion, has no significant news recently. The trading is active, and the capital flow is evident. Considering the sector and industry trends, this stock shows significant volatility, and the specific reasons need further observation